Novel Retinoic Acid Receptor Alpha Agonists for Treatment of Kidney Disease

Development of pharmacologic agents that protect podocytes from injury is a critical strategy for the treatment of kidney glomerular diseases. Retinoic acid reduces proteinuria and glomerulosclerosis in multiple animal models of kidney diseases. However, clinical studies are limited because of signi...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Prif Awduron: Zhong, Yifei, Wu, Yingwei, Liu, Ruijie, Li, Zhengzhe, Chen, Yibang, Evans, Todd, Chuang, Peter, Das, Bhaskar, He, John Cijiang
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Public Library of Science 2011
Pynciau:
Research Article
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC3220717/
https://ncbi.nlm.nih.gov/pubmed/22125642
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0027945
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg